Foghorn Therapeutics Inc (FHTX) — Capital Reinvestment Ratio
Foghorn Therapeutics Inc (FHTX) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($271.53 Million) in capital expenditures ($247.00K). See FHTX equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Foghorn Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Foghorn Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Foghorn Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Foghorn Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Foghorn Therapeutics Inc from 2022 to 2022. For live market cap and broader valuation context, see FHTX market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $193.61 Million | $1.21 Million | — |